This fact was also observed in other animal models of autoimmune diseases such as Crohn's disease, multiple sclerosis, and autoimmune diabetes [37, 104] regardless of the way of administration since “in vivo” delivery of lentiviral vectors expressing VIP complementary DNA had the same effect than intraperitoneal administration of VIP [105]. Here, VIP is linked to autoimmune disease.